Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 29 articles: HTML format

Single Articles

June 2025
1. GUPTA S, Rau RE, Loh ML
   Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia. Reply.
   N Engl J Med. 2025;392:2286-2287.
   PubMed    
   
   
   
2. HODDER A, Vora A, Samarasinghe S
   Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia.
   N Engl J Med. 2025;392:2286.
   PubMed    
   
   
   
3. BROWN JR, Miller K, Munugalavadla V
   Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. Reply.
   N Engl J Med. 2025;392:2181.
   PubMed    
   
   
   
4. MOHTY M, Kharfan-Dabaja MA
   Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
   N Engl J Med. 2025;392:2180-2181.
   PubMed    
   
   
   May 2025
5. FOA R
   Ph-Positive Acute Lymphoblastic Leukemia - 25 Years of Progress.
   N Engl J Med. 2025;392:1941-1952.
   PubMed    
   
   
   April 2025
6. SANTI A, Venanzi A, Pucciarini A, Schiavoni G, et al
   Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia.
   N Engl J Med. 2025;392:1451-1452.
   PubMed    
   
   
   February 2025
7. BROWN JR, Seymour JF, Jurczak W, Aw A, et al
   Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
   N Engl J Med. 2025;392:748-762.
   PubMed     Abstract available
   
   
   January 2025
8. BASHIR BA
   Chronic Myeloid Leukemia with Hyperleukocytosis.
   N Engl J Med. 2025;392:72.
   PubMed    
   
   
   December 2024
9. FALINI B, Tiacci E
   Hairy-Cell Leukemia. Reply.
   N Engl J Med. 2024;391:2388.
   PubMed    
   
   
   
10. HERMEL DJ, Saven A
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:2387-2388.
    PubMed    
    
    
    
11. REINHOLD I, Cornely OA, Stemler J
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:2386-2387.
    PubMed    
    
    
    
12. ABRUZZESE E
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. Reply.
    N Engl J Med. 2024;391:2276.
    PubMed    
    
    
    
13. HOCHHAUS A, Cortes JE, Hughes TP
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. Reply.
    N Engl J Med. 2024;391:2275-2276.
    PubMed    
    
    
    
14. PUNWANI N
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024;391:2275.
    PubMed    
    
    
    
15. GAMBACORTI-PASSERINI C, Piazza R
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024;391:2274-2275.
    PubMed    
    
    
    
16. GUPTA S, Rau RE, Kairalla JA, Rabin KR, et al
    Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
    N Engl J Med. 2024 Dec 7. doi: 10.1056/NEJMoa2411680.
    PubMed     Abstract available
    
    
    November 2024
17. RODDIE C, Sandhu KS, Tholouli E, Logan AC, et al
    Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
    N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2406526.
    PubMed     Abstract available
    
    
    October 2024
18. FALINI B, Tiacci E
    Hairy-Cell Leukemia.
    N Engl J Med. 2024;391:1328-1341.
    PubMed    
    
    
    September 2024
19. ABRUZZESE E
    CML 25 Years Later - Poised for Another Breakthrough?
    N Engl J Med. 2024;391:955-957.
    PubMed    
    
    
    August 2024
20. HSU C, Konner JA, Gounder MM
    Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
    N Engl J Med. 2024;391:770-772.
    PubMed    
    
    
    July 2024
21. LITZOW MR, Sun Z, Mattison RJ, Paietta EM, et al
    Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
    N Engl J Med. 2024;391:320-333.
    PubMed     Abstract available
    
    
    June 2024
22. TIONG IS, Ritchie DS, Blombery P
    Response and Resistance to Menin Inhibitor in UBTF-Tandem Duplication AML.
    N Engl J Med. 2024;390:2323-2325.
    PubMed    
    
    
    May 2024
23. HOCHHAUS A, Wang J, Kim DW, Kim DDH, et al
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024 May 31. doi: 10.1056/NEJMoa2400858.
    PubMed     Abstract available
    
    
    
24. MUNIR T, Hillmen P
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.
    N Engl J Med. 2024;390:1634-1635.
    PubMed    
    
    
    
25. WANG WD, Gale RP, Liang Y
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2024;390:1633-1634.
    PubMed    
    
    
    
26. WINKLER C
    Acute Promyelocytic Leukemia.
    N Engl J Med. 2024;390:e42.
    PubMed    
    
    
    April 2024
27. BLAISE D
    CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
    N Engl J Med. 2024;390:1526-1527.
    PubMed    
    
    
    
28. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    PubMed     Abstract available
    
    
    December 2023
29. MUNIR T, Cairns DA, Bloor A, Allsup D, et al
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2023 Dec 10. doi: 10.1056/NEJMoa2310063.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.